Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
RaySearch Laboratories AB ( ($SE:RAY.B) ) just unveiled an announcement.
At the Annual General Meeting 2025, RaySearch Laboratories AB re-elected its board members and chairman, approved financial statements, and declared a dividend of SEK 3 per share. The meeting also re-elected Deloitte AB as the auditor and approved executive remuneration guidelines, reflecting stability and continuity in the company’s governance. These resolutions are likely to reinforce RaySearch’s strategic direction and reassure stakeholders of its commitment to financial and operational transparency.
More about RaySearch Laboratories AB
RaySearch Laboratories AB is a medical technology company specializing in innovative software solutions for cancer treatment. The company offers products such as the RayStation treatment planning system, RayCare oncology information system, RayIntelligence oncology analytics system, and RayCommand treatment control system. Founded in 2000 as a spin-off from the Karolinska Institute, RaySearch has sold its software to over 1,100 clinics in 47 countries and is listed on Nasdaq Stockholm.
Average Trading Volume: 193,828
Current Market Cap: SEK10.75B
Learn more about RAY.B stock on TipRanks’ Stock Analysis page.